Cargando…
Mini-Review: Can the Metastatic Cascade Be Inhibited by Targeting CD147/EMMPRIN to Prevent Tumor Recurrence?
Solid tumors metastasize very early in their development, and once the metastatic cell is lodged in a remote organ, it can proliferate to generate a metastatic lesion or remain dormant for long periods. Dormant cells represent a real risk for future tumor recurrence, but because they are typically u...
Autor principal: | Rahat, Michal A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995701/ https://www.ncbi.nlm.nih.gov/pubmed/35418981 http://dx.doi.org/10.3389/fimmu.2022.855978 |
Ejemplares similares
-
The role of EMMPRIN/CD147 in regulating angiogenesis in patients with psoriatic arthritis
por: Rahat, Michal A., et al.
Publicado: (2020) -
Tocilizumab (TCZ) Decreases Angiogenesis in Rheumatoid Arthritis Through Its Regulatory Effect on miR-146a-5p and EMMPRIN/CD147
por: Zisman, Devy, et al.
Publicado: (2021) -
Knocking-Down CD147/EMMPRIN Expression in CT26 Colon Carcinoma Forces the Cells into Cellular and Angiogenic Dormancy That Can Be Reversed by Interactions with Macrophages
por: Feigelman, Gabriele, et al.
Publicado: (2023) -
Extracellular Matrix Metalloproteinase Inducer EMMPRIN (CD147) in Cardiovascular Disease
por: von Ungern-Sternberg, Saskia N. I., et al.
Publicado: (2018) -
The Effects of EMMPRIN/CD147 on Late Function and Histopathological Lesions of the Renal Graft
por: Nalewajska, Magdalena, et al.
Publicado: (2022)